Please wait
0000874015424B5EX-FILING FEESfalseCommon stock, par value $0.001 per share 0000874015 2024-09-10 2024-09-10 0000874015 1 2024-09-10 2024-09-10 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
S-3
Ionis Pharmaceuticals, Inc.
Table 1: Newly Registered and Carry Forward Securities
 
                           
        
Security 
Type
 
Security
Class Title
 
Fee
 Calculation 
or Carry
Forward
Rule
 
Amount
 Registered 
 
Proposed
 Maximum 
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
 Registration 
Fee
 
Carry
 Forward 
Form
Type
 
Carry
 Forward 
File
Number
 
Carry
 Forward 
Initial
Effective
Date
 
Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                           
Fees to be
Paid
   1    Equity  
Common  stock, par value $0.001 per share
  457(r)  
13,225,000

  $
43.50
  $575,287,500.00   $0.0001476   $84,912.44        
 
                           
Fees
Previously
Paid
                         
 
 
Carry Forward Securities
                           
Carry
Forward
Securities
                         
 
                     
 
    Total Offering Amounts:     $575,287,500.00     $84,912.44        
 
                     
 
    Total Fees Previously Paid:         $0.00        
 
                     
 
    Total Fee Offsets:         $0.00        
 
                     
 
 
 
  Net Fee Due:  
 
 
 
 
 
  $84,912.44  
 
 
 
 
 
 
 
Offering Note
 
1
Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). Payment of the registration fee at the time of filing of the registrant’s Registration Statement on Form
S-3
(File
No. 333-275741)
on November 24, 2023 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith.
Includes
1,725,000
shares of common stock that the underwriters have an option to purchase.